Zobrazeno 1 - 10
of 134
pro vyhledávání: '"de Cassan S"'
Autor:
Dalton LJ; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom., de Cassan S; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom.; Oxford Health National Health Service (NHS) Foundation Trust, Oxford, United Kingdom., Ilyas A; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom.; Oxford Health National Health Service (NHS) Foundation Trust, Oxford, United Kingdom., Dunn A; School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, United Kingdom., Rapa E; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Frontiers in psychiatry [Front Psychiatry] 2024 Oct 23; Vol. 15, pp. 1463823. Date of Electronic Publication: 2024 Oct 23 (Print Publication: 2024).
Autor:
Moltrecht B; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK.; Evidence-Base Practice Unit, University College London, London, N1 9JH, UK.; Centre for Longitudinal Studies, University College London, London, WC1H 0NU, UK., de Cassan S; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK., Rapa E; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK., Hanna JR; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK.; School of Nursing and Midwifery, Queen's University Belfast, Belfast, BT9 7BL, UK., Law C; Centre for Early Child Development, Blackpool Better Start (NSPCC), Blackpool, UK., Dalton LJ; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, OX3 7JX, UK. Louise.dalton@psych.ox.ac.uk.
Publikováno v:
BMC health services research [BMC Health Serv Res] 2022 Aug 12; Vol. 22 (1), pp. 1026. Date of Electronic Publication: 2022 Aug 12.
Autor:
de Cassan S; Department of Psychiatry, University of Oxford, Oxford, RU., Thompson MJ; Department of Family Medicine, University of Washington, Seattle, WA, EE.UU., Perera R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, RU., Glasziou PP; Centre for Research in Evidence-Based Practice (CREBP), Bond University, Gold Coast, Australia., Del Mar CB; Centre for Research in Evidence-Based Practice (CREBP), Bond University, Gold Coast, Australia., Heneghan CJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, RU., Hayward G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, RU.
Publikováno v:
Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias [Emergencias] 2022 Aug; Vol. 34 (4), pp. 308-309.
Autor:
Chuan, W, Hart, M, Chui, C, Ajuogu, A, Brian, I, de Cassan, S, Borrow, P, Draper, S, Douglas, A
Publikováno v:
The Journal of Immunology
The Journal of Immunology Author Choice
The Journal of Immunology Author Choice
There is great interest in the development of Ab-inducing subunit vaccines targeting infections, including HIV, malaria, and Ebola. We previously reported that adenovirus vectored vaccines are potent in priming Ab responses, but uncertainty remains r
Autor:
de Cassan, S
The vaccine field generally accepts that the induction of high-titre antibodies will be necessary to prevent the invasion of erythrocytes utilising vaccines targeting the blood-stage of malaria. Protein-in-adjuvant formulations are commonly used to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1064::62226e843076f27c74c4cb9ce620ba46
https://ora.ox.ac.uk/objects/uuid:19e5644d-63e0-4f73-9b98-f869660a6494
https://ora.ox.ac.uk/objects/uuid:19e5644d-63e0-4f73-9b98-f869660a6494
Autor:
Hodgson, SH, Ewer, KJ, Bliss, CM, Edwards, NJ, Rampling, T, Anagnostou, NA, de Barra, E, Havelock, T, Bowyer, G, Poulton, ID, de Cassan, S, Longley, R, Illingworth, JJ, Douglas, AD, Mange, PB, Collins, KA, Roberts, R, Gerry, S, Berrie, E, Moyle, S, Colloca, S, Cortese, R, Sinden, RE, Gilbert, SC, Bejon, P, Lawrie, AM, Nicosia, A, Faust, SN, Hill, AV
Publikováno v:
The Journal of Infectious Diseases
Background: Circumsporozoite protein (CS) is the antigenic target for RTS,S, the most advanced malaria vaccine to date. Heterologous prime-boost with the viral vectors simian adenovirus 63 (ChAd63)-modified vaccinia virus Ankara (MVA) is the most pot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::76aa1800a4aa2a5df96b5a1ffe0a3cf7
https://doi.org/10.1093/infdis/jiu579
https://doi.org/10.1093/infdis/jiu579
Autor:
Li, Y, Leneghan, D, Miura, K, Nikolaeva, D, Brian, I, Dicks, M, Fyfe, A, Zakutansky, S, de Cassan, S, Long, C, Draper, S, Hill, A, Hill, F, Biswas, S
Publikováno v:
Scientific Reports. 6
Transmission-blocking vaccines (TBV) target the sexual-stages of the malaria parasite in the mosquito midgut and are widely considered to be an essential tool for malaria elimination. High-titer functional antibodies are required against target antig
Autor:
Appelgren Engström, Heléne1,2 (AUTHOR) helene.appelgren.engstrom@mdu.se, Golsäter, Marie3,4 (AUTHOR), Harder, Maria1,2 (AUTHOR)
Publikováno v:
BMC Public Health. 10/29/2024, Vol. 24 Issue 1, p1-9. 9p.
Autor:
Butler J; Foundation Year 3 Physical Health Care, Department of Psychiatry, University of Oxford, Oxford, UK. Joseph.Butler@psych.ox.ac.uk., de Cassan S; Core trainee Psychiatry, Oxford Health NHS Foundation Trust, Oxford, UK., Turner P; NIHR Community Healthcare MIC, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Lennox B; Oxford Health NHS Foundation Trust, UK and Professor of Psychiatry, Department of Psychiatry, University of Oxford, Oxford, UK., Hayward G; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Glogowska M; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Publikováno v:
BMC psychiatry [BMC Psychiatry] 2021 Feb 04; Vol. 21 (1), pp. 73. Date of Electronic Publication: 2021 Feb 04.
Autor:
Hodgson, S.H., Ewer, K.J., Bliss, C.M., Edwards, N.J., Rampling, T., Anagnostou, N.A., de Barra, E., Havelock, T., Bowyer, G., Poulton, I.D., de Cassan, S., Illingworth, J.J., Douglas, A.D., Mange, P.B., Collins, K.A., Roberts, R., Gerry, S., Berrie, E., Moyle, S., Colloca, S., Cortese, R., Sinden, R.E., Gilbert, S.C., Bejon, P., Lawrie, A.M., Nicosia, A., Faust, S.N ., Hill, A.V.
Background.?Circumsporozoite protein (CS) is the antigenic target for RTS,S, the most advanced malaria vaccine to date. Heterologous prime-boost with the viral vectors ChAd63-MVA is the most potent inducer of T-cells in humans, demonstrating signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______348::a1e223b13044c061ce4b61517c3326e8
https://eprints.soton.ac.uk/371775/
https://eprints.soton.ac.uk/371775/